The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Smallpox Vaccine Market Research Report 2025
Synopsis
Smallpox vaccine develops immunity and protect people from smallpox. This smallpox vaccine is made from the virus called Vaccinia.
The global Smallpox Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Smallpox Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Smallpox Vaccine.
Report Scope
The Smallpox Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Smallpox Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Smallpox Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bavarian Nordic
CEL-SCI
Chimerix
EpiVax
Nanotherapeutics
Oncovir
SIGA Technologies
Symphogen
TapImmune
Tonix Pharmaceuticals Holding
Segment by Type
First Generation
Second Generation
Third Generation
Segment by Application
Government Hospital And Program
Private Hospitals / Clinicss
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Smallpox Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Smallpox Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Smallpox vaccine develops immunity and protect people from smallpox. This smallpox vaccine is made from the virus called Vaccinia.
The global Smallpox Vaccine market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Smallpox Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Smallpox Vaccine.
Report Scope
The Smallpox Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Smallpox Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Smallpox Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Bavarian Nordic
CEL-SCI
Chimerix
EpiVax
Nanotherapeutics
Oncovir
SIGA Technologies
Symphogen
TapImmune
Tonix Pharmaceuticals Holding
Segment by Type
First Generation
Second Generation
Third Generation
Segment by Application
Government Hospital And Program
Private Hospitals / Clinicss
Consumption by Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Smallpox Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Smallpox Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Smallpox Vaccine Market Overview
1.1 Product Overview and Scope of Smallpox Vaccine
1.2 Smallpox Vaccine Segment by Type
1.2.1 Global Smallpox Vaccine Market Value Comparison by Type (2024-2030)
1.2.2 First Generation
1.2.3 Second Generation
1.2.4 Third Generation
1.3 Smallpox Vaccine Segment by Application
1.3.1 Global Smallpox Vaccine Market Value by Application: (2024-2030)
1.3.2 Government Hospital And Program
1.3.3 Private Hospitals / Clinicss
1.4 Global Smallpox Vaccine Market Size Estimates and Forecasts
1.4.1 Global Smallpox Vaccine Revenue 2019-2030
1.4.2 Global Smallpox Vaccine Sales 2019-2030
1.4.3 Global Smallpox Vaccine Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Smallpox Vaccine Market Competition by Manufacturers
2.1 Global Smallpox Vaccine Sales Market Share by Manufacturers (2019-2024)
2.2 Global Smallpox Vaccine Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Smallpox Vaccine Average Price by Manufacturers (2019-2024)
2.4 Global Smallpox Vaccine Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Smallpox Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Smallpox Vaccine, Product Type & Application
2.7 Smallpox Vaccine Market Competitive Situation and Trends
2.7.1 Smallpox Vaccine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Smallpox Vaccine Players Market Share by Revenue
2.7.3 Global Smallpox Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Smallpox Vaccine Retrospective Market Scenario by Region
3.1 Global Smallpox Vaccine Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Smallpox Vaccine Global Smallpox Vaccine Sales by Region: 2019-2030
3.2.1 Global Smallpox Vaccine Sales by Region: 2019-2024
3.2.2 Global Smallpox Vaccine Sales by Region: 2025-2030
3.3 Global Smallpox Vaccine Global Smallpox Vaccine Revenue by Region: 2019-2030
3.3.1 Global Smallpox Vaccine Revenue by Region: 2019-2024
3.3.2 Global Smallpox Vaccine Revenue by Region: 2025-2030
3.4 North America Smallpox Vaccine Market Facts & Figures by Country
3.4.1 North America Smallpox Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Smallpox Vaccine Sales by Country (2019-2030)
3.4.3 North America Smallpox Vaccine Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Smallpox Vaccine Market Facts & Figures by Country
3.5.1 Europe Smallpox Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Smallpox Vaccine Sales by Country (2019-2030)
3.5.3 Europe Smallpox Vaccine Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Smallpox Vaccine Market Facts & Figures by Country
3.6.1 Asia Pacific Smallpox Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Smallpox Vaccine Sales by Country (2019-2030)
3.6.3 Asia Pacific Smallpox Vaccine Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Smallpox Vaccine Market Facts & Figures by Country
3.7.1 Latin America Smallpox Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Smallpox Vaccine Sales by Country (2019-2030)
3.7.3 Latin America Smallpox Vaccine Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Smallpox Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Smallpox Vaccine Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Smallpox Vaccine Sales by Country (2019-2030)
3.8.3 Middle East and Africa Smallpox Vaccine Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Smallpox Vaccine Sales by Type (2019-2030)
4.1.1 Global Smallpox Vaccine Sales by Type (2019-2024)
4.1.2 Global Smallpox Vaccine Sales by Type (2025-2030)
4.1.3 Global Smallpox Vaccine Sales Market Share by Type (2019-2030)
4.2 Global Smallpox Vaccine Revenue by Type (2019-2030)
4.2.1 Global Smallpox Vaccine Revenue by Type (2019-2024)
4.2.2 Global Smallpox Vaccine Revenue by Type (2025-2030)
4.2.3 Global Smallpox Vaccine Revenue Market Share by Type (2019-2030)
4.3 Global Smallpox Vaccine Price by Type (2019-2030)
5 Segment by Application
5.1 Global Smallpox Vaccine Sales by Application (2019-2030)
5.1.1 Global Smallpox Vaccine Sales by Application (2019-2024)
5.1.2 Global Smallpox Vaccine Sales by Application (2025-2030)
5.1.3 Global Smallpox Vaccine Sales Market Share by Application (2019-2030)
5.2 Global Smallpox Vaccine Revenue by Application (2019-2030)
5.2.1 Global Smallpox Vaccine Revenue by Application (2019-2024)
5.2.2 Global Smallpox Vaccine Revenue by Application (2025-2030)
5.2.3 Global Smallpox Vaccine Revenue Market Share by Application (2019-2030)
5.3 Global Smallpox Vaccine Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Bavarian Nordic
6.1.1 Bavarian Nordic Corporation Information
6.1.2 Bavarian Nordic Description and Business Overview
6.1.3 Bavarian Nordic Smallpox Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Bavarian Nordic Smallpox Vaccine Product Portfolio
6.1.5 Bavarian Nordic Recent Developments/Updates
6.2 CEL-SCI
6.2.1 CEL-SCI Corporation Information
6.2.2 CEL-SCI Description and Business Overview
6.2.3 CEL-SCI Smallpox Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.2.4 CEL-SCI Smallpox Vaccine Product Portfolio
6.2.5 CEL-SCI Recent Developments/Updates
6.3 Chimerix
6.3.1 Chimerix Corporation Information
6.3.2 Chimerix Description and Business Overview
6.3.3 Chimerix Smallpox Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Chimerix Smallpox Vaccine Product Portfolio
6.3.5 Chimerix Recent Developments/Updates
6.4 EpiVax
6.4.1 EpiVax Corporation Information
6.4.2 EpiVax Description and Business Overview
6.4.3 EpiVax Smallpox Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 EpiVax Smallpox Vaccine Product Portfolio
6.4.5 EpiVax Recent Developments/Updates
6.5 Nanotherapeutics
6.5.1 Nanotherapeutics Corporation Information
6.5.2 Nanotherapeutics Description and Business Overview
6.5.3 Nanotherapeutics Smallpox Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Nanotherapeutics Smallpox Vaccine Product Portfolio
6.5.5 Nanotherapeutics Recent Developments/Updates
6.6 Oncovir
6.6.1 Oncovir Corporation Information
6.6.2 Oncovir Description and Business Overview
6.6.3 Oncovir Smallpox Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Oncovir Smallpox Vaccine Product Portfolio
6.6.5 Oncovir Recent Developments/Updates
6.7 SIGA Technologies
6.6.1 SIGA Technologies Corporation Information
6.6.2 SIGA Technologies Description and Business Overview
6.6.3 SIGA Technologies Smallpox Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.4.4 SIGA Technologies Smallpox Vaccine Product Portfolio
6.7.5 SIGA Technologies Recent Developments/Updates
6.8 Symphogen
6.8.1 Symphogen Corporation Information
6.8.2 Symphogen Description and Business Overview
6.8.3 Symphogen Smallpox Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Symphogen Smallpox Vaccine Product Portfolio
6.8.5 Symphogen Recent Developments/Updates
6.9 TapImmune
6.9.1 TapImmune Corporation Information
6.9.2 TapImmune Description and Business Overview
6.9.3 TapImmune Smallpox Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.9.4 TapImmune Smallpox Vaccine Product Portfolio
6.9.5 TapImmune Recent Developments/Updates
6.10 Tonix Pharmaceuticals Holding
6.10.1 Tonix Pharmaceuticals Holding Corporation Information
6.10.2 Tonix Pharmaceuticals Holding Description and Business Overview
6.10.3 Tonix Pharmaceuticals Holding Smallpox Vaccine Sales, Revenue and Gross Margin (2019-2024)
6.10.4 Tonix Pharmaceuticals Holding Smallpox Vaccine Product Portfolio
6.10.5 Tonix Pharmaceuticals Holding Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Smallpox Vaccine Industry Chain Analysis
7.2 Smallpox Vaccine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Smallpox Vaccine Production Mode & Process
7.4 Smallpox Vaccine Sales and Marketing
7.4.1 Smallpox Vaccine Sales Channels
7.4.2 Smallpox Vaccine Distributors
7.5 Smallpox Vaccine Customers
8 Smallpox Vaccine Market Dynamics
8.1 Smallpox Vaccine Industry Trends
8.2 Smallpox Vaccine Market Drivers
8.3 Smallpox Vaccine Market Challenges
8.4 Smallpox Vaccine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Smallpox Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
Table 2. Global Smallpox Vaccine Market Value Comparison by Application (2024-2030) & (US$ Million)
Table 3. Global Smallpox Vaccine Market Competitive Situation by Manufacturers in 2023
Table 4. Global Smallpox Vaccine Sales (K Units) of Key Manufacturers (2019-2024)
Table 5. Global Smallpox Vaccine Sales Market Share by Manufacturers (2019-2024)
Table 6. Global Smallpox Vaccine Revenue (US$ Million) by Manufacturers (2019-2024)
Table 7. Global Smallpox Vaccine Revenue Share by Manufacturers (2019-2024)
Table 8. Global Market Smallpox Vaccine Average Price (USD/Unit) of Key Manufacturers (2019-2024)
Table 9. Global Key Players of Smallpox Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Smallpox Vaccine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Smallpox Vaccine, Product Type & Application
Table 12. Global Key Manufacturers of Smallpox Vaccine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Smallpox Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Smallpox Vaccine as of 2023)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Smallpox Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 17. Global Smallpox Vaccine Sales by Region (2019-2024) & (K Units)
Table 18. Global Smallpox Vaccine Sales Market Share by Region (2019-2024)
Table 19. Global Smallpox Vaccine Sales by Region (2025-2030) & (K Units)
Table 20. Global Smallpox Vaccine Sales Market Share by Region (2025-2030)
Table 21. Global Smallpox Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 22. Global Smallpox Vaccine Revenue Market Share by Region (2019-2024)
Table 23. Global Smallpox Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 24. Global Smallpox Vaccine Revenue Market Share by Region (2025-2030)
Table 25. North America Smallpox Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 26. North America Smallpox Vaccine Sales by Country (2019-2024) & (K Units)
Table 27. North America Smallpox Vaccine Sales by Country (2025-2030) & (K Units)
Table 28. North America Smallpox Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 29. North America Smallpox Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 30. Europe Smallpox Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 31. Europe Smallpox Vaccine Sales by Country (2019-2024) & (K Units)
Table 32. Europe Smallpox Vaccine Sales by Country (2025-2030) & (K Units)
Table 33. Europe Smallpox Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 34. Europe Smallpox Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 35. Asia Pacific Smallpox Vaccine Revenue by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 36. Asia Pacific Smallpox Vaccine Sales by Region (2019-2024) & (K Units)
Table 37. Asia Pacific Smallpox Vaccine Sales by Region (2025-2030) & (K Units)
Table 38. Asia Pacific Smallpox Vaccine Revenue by Region (2019-2024) & (US$ Million)
Table 39. Asia Pacific Smallpox Vaccine Revenue by Region (2025-2030) & (US$ Million)
Table 40. Latin America Smallpox Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Latin America Smallpox Vaccine Sales by Country (2019-2024) & (K Units)
Table 42. Latin America Smallpox Vaccine Sales by Country (2025-2030) & (K Units)
Table 43. Latin America Smallpox Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 44. Latin America Smallpox Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 45. Middle East & Africa Smallpox Vaccine Revenue by Country: 2019 VS 2023 VS 2030 (US$ Million)
Table 46. Middle East & Africa Smallpox Vaccine Sales by Country (2019-2024) & (K Units)
Table 47. Middle East & Africa Smallpox Vaccine Sales by Country (2025-2030) & (K Units)
Table 48. Middle East & Africa Smallpox Vaccine Revenue by Country (2019-2024) & (US$ Million)
Table 49. Middle East & Africa Smallpox Vaccine Revenue by Country (2025-2030) & (US$ Million)
Table 50. Global Smallpox Vaccine Sales (K Units) by Type (2019-2024)
Table 51. Global Smallpox Vaccine Sales (K Units) by Type (2025-2030)
Table 52. Global Smallpox Vaccine Sales Market Share by Type (2019-2024)
Table 53. Global Smallpox Vaccine Sales Market Share by Type (2025-2030)
Table 54. Global Smallpox Vaccine Revenue (US$ Million) by Type (2019-2024)
Table 55. Global Smallpox Vaccine Revenue (US$ Million) by Type (2025-2030)
Table 56. Global Smallpox Vaccine Revenue Market Share by Type (2019-2024)
Table 57. Global Smallpox Vaccine Revenue Market Share by Type (2025-2030)
Table 58. Global Smallpox Vaccine Price (USD/Unit) by Type (2019-2024)
Table 59. Global Smallpox Vaccine Price (USD/Unit) by Type (2025-2030)
Table 60. Global Smallpox Vaccine Sales (K Units) by Application (2019-2024)
Table 61. Global Smallpox Vaccine Sales (K Units) by Application (2025-2030)
Table 62. Global Smallpox Vaccine Sales Market Share by Application (2019-2024)
Table 63. Global Smallpox Vaccine Sales Market Share by Application (2025-2030)
Table 64. Global Smallpox Vaccine Revenue (US$ Million) by Application (2019-2024)
Table 65. Global Smallpox Vaccine Revenue (US$ Million) by Application (2025-2030)
Table 66. Global Smallpox Vaccine Revenue Market Share by Application (2019-2024)
Table 67. Global Smallpox Vaccine Revenue Market Share by Application (2025-2030)
Table 68. Global Smallpox Vaccine Price (USD/Unit) by Application (2019-2024)
Table 69. Global Smallpox Vaccine Price (USD/Unit) by Application (2025-2030)
Table 70. Bavarian Nordic Corporation Information
Table 71. Bavarian Nordic Description and Business Overview
Table 72. Bavarian Nordic Smallpox Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 73. Bavarian Nordic Smallpox Vaccine Product
Table 74. Bavarian Nordic Recent Developments/Updates
Table 75. CEL-SCI Corporation Information
Table 76. CEL-SCI Description and Business Overview
Table 77. CEL-SCI Smallpox Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 78. CEL-SCI Smallpox Vaccine Product
Table 79. CEL-SCI Recent Developments/Updates
Table 80. Chimerix Corporation Information
Table 81. Chimerix Description and Business Overview
Table 82. Chimerix Smallpox Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 83. Chimerix Smallpox Vaccine Product
Table 84. Chimerix Recent Developments/Updates
Table 85. EpiVax Corporation Information
Table 86. EpiVax Description and Business Overview
Table 87. EpiVax Smallpox Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 88. EpiVax Smallpox Vaccine Product
Table 89. EpiVax Recent Developments/Updates
Table 90. Nanotherapeutics Corporation Information
Table 91. Nanotherapeutics Description and Business Overview
Table 92. Nanotherapeutics Smallpox Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 93. Nanotherapeutics Smallpox Vaccine Product
Table 94. Nanotherapeutics Recent Developments/Updates
Table 95. Oncovir Corporation Information
Table 96. Oncovir Description and Business Overview
Table 97. Oncovir Smallpox Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 98. Oncovir Smallpox Vaccine Product
Table 99. Oncovir Recent Developments/Updates
Table 100. SIGA Technologies Corporation Information
Table 101. SIGA Technologies Description and Business Overview
Table 102. SIGA Technologies Smallpox Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 103. SIGA Technologies Smallpox Vaccine Product
Table 104. SIGA Technologies Recent Developments/Updates
Table 105. Symphogen Corporation Information
Table 106. Symphogen Description and Business Overview
Table 107. Symphogen Smallpox Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 108. Symphogen Smallpox Vaccine Product
Table 109. Symphogen Recent Developments/Updates
Table 110. TapImmune Corporation Information
Table 111. TapImmune Description and Business Overview
Table 112. TapImmune Smallpox Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 113. TapImmune Smallpox Vaccine Product
Table 114. TapImmune Recent Developments/Updates
Table 115. Tonix Pharmaceuticals Holding Corporation Information
Table 116. Tonix Pharmaceuticals Holding Description and Business Overview
Table 117. Tonix Pharmaceuticals Holding Smallpox Vaccine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2019-2024)
Table 118. Tonix Pharmaceuticals Holding Smallpox Vaccine Product
Table 119. Tonix Pharmaceuticals Holding Recent Developments/Updates
Table 120. Key Raw Materials Lists
Table 121. Raw Materials Key Suppliers Lists
Table 122. Smallpox Vaccine Distributors List
Table 123. Smallpox Vaccine Customers List
Table 124. Smallpox Vaccine Market Trends
Table 125. Smallpox Vaccine Market Drivers
Table 126. Smallpox Vaccine Market Challenges
Table 127. Smallpox Vaccine Market Restraints
Table 128. Research Programs/Design for This Report
Table 129. Key Data Information from Secondary Sources
Table 130. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Smallpox Vaccine
Figure 2. Global Smallpox Vaccine Market Value Comparison by Type (2024-2030) & (US$ Million)
Figure 3. Global Smallpox Vaccine Market Share by Type in 2023 & 2030
Figure 4. First Generation Product Picture
Figure 5. Second Generation Product Picture
Figure 6. Third Generation Product Picture
Figure 7. Global Smallpox Vaccine Market Value Comparison by Application (2024-2030) & (US$ Million)
Figure 8. Global Smallpox Vaccine Market Share by Application in 2023 & 2030
Figure 9. Government Hospital And Program
Figure 10. Private Hospitals / Clinicss
Figure 11. Global Smallpox Vaccine Revenue, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Smallpox Vaccine Market Size (2019-2030) & (US$ Million)
Figure 13. Global Smallpox Vaccine Sales (2019-2030) & (K Units)
Figure 14. Global Smallpox Vaccine Average Price (USD/Unit) & (2019-2030)
Figure 15. Smallpox Vaccine Report Years Considered
Figure 16. Smallpox Vaccine Sales Share by Manufacturers in 2023
Figure 17. Global Smallpox Vaccine Revenue Share by Manufacturers in 2023
Figure 18. The Global 5 and 10 Largest Smallpox Vaccine Players: Market Share by Revenue in 2023
Figure 19. Smallpox Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2019 VS 2023
Figure 20. Global Smallpox Vaccine Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Figure 21. North America Smallpox Vaccine Sales Market Share by Country (2019-2030)
Figure 22. North America Smallpox Vaccine Revenue Market Share by Country (2019-2030)
Figure 23. U.S. Smallpox Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 24. Canada Smallpox Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 25. Europe Smallpox Vaccine Sales Market Share by Country (2019-2030)
Figure 26. Europe Smallpox Vaccine Revenue Market Share by Country (2019-2030)
Figure 27. Germany Smallpox Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 28. France Smallpox Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 29. U.K. Smallpox Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 30. Italy Smallpox Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 31. Russia Smallpox Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 32. Asia Pacific Smallpox Vaccine Sales Market Share by Region (2019-2030)
Figure 33. Asia Pacific Smallpox Vaccine Revenue Market Share by Region (2019-2030)
Figure 34. China Smallpox Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 35. Japan Smallpox Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 36. South Korea Smallpox Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 37. India Smallpox Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 38. Australia Smallpox Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 39. Taiwan Smallpox Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 40. Indonesia Smallpox Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 41. Thailand Smallpox Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 42. Malaysia Smallpox Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 43. Philippines Smallpox Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 44. Latin America Smallpox Vaccine Sales Market Share by Country (2019-2030)
Figure 45. Latin America Smallpox Vaccine Revenue Market Share by Country (2019-2030)
Figure 46. Mexico Smallpox Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 47. Brazil Smallpox Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 48. Argentina Smallpox Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 49. Middle East & Africa Smallpox Vaccine Sales Market Share by Country (2019-2030)
Figure 50. Middle East & Africa Smallpox Vaccine Revenue Market Share by Country (2019-2030)
Figure 51. Turkey Smallpox Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 52. Saudi Arabia Smallpox Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 53. UAE Smallpox Vaccine Revenue Growth Rate (2019-2030) & (US$ Million)
Figure 54. Global Sales Market Share of Smallpox Vaccine by Type (2019-2030)
Figure 55. Global Revenue Market Share of Smallpox Vaccine by Type (2019-2030)
Figure 56. Global Smallpox Vaccine Price (USD/Unit) by Type (2019-2030)
Figure 57. Global Sales Market Share of Smallpox Vaccine by Application (2019-2030)
Figure 58. Global Revenue Market Share of Smallpox Vaccine by Application (2019-2030)
Figure 59. Global Smallpox Vaccine Price (USD/Unit) by Application (2019-2030)
Figure 60. Smallpox Vaccine Value Chain
Figure 61. Smallpox Vaccine Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
